{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:01:20Z","timestamp":1790755280947,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.oret.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:09:21Z","timestamp":1786882161000},"page":"981-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tetracycline-class Antibiotics for Proliferative Retinopathy Prevention: Still Too Many Unanswered Questions"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-1124","authenticated-orcid":false,"given":"Mathew W.","family":"MacCumber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan G.","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.oret.2024.06.007","article-title":"Risk of proliferative vitreoretinopathy in the second eye in adult patients with bilateral retinal detachment","volume":"8","author":"Shepherd","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/IAE.0000000000004391","article-title":"Risk factors for proliferative vitreoretinopathy in a large clinical database","volume":"45","author":"Oncel","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.oret.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/ICU.0000000000001119","article-title":"Recent advances in pharmacological treatments of proliferative vitreoretinopathy","volume":"36","author":"Sanchez-Suarez","year":"2025","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/jop.2022.0078","article-title":"Pharmacological therapy of proliferative vitreoretinopathy: systematic in vitro comparison of 36 pharmacological agents","volume":"39","author":"Tersi","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.oret.2026.04.017","article-title":"Tetracyclines and risk of proliferative vitreoretinopathy following rhegmatogenous retinal detachment","volume":"10","author":"Nitzan","year":"2026","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.survophthal.2023.05.007","article-title":"In vitro laboratory models of proliferative vitreoretinopathy","volume":"68","author":"Gao","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.3390\/ijms24054509","article-title":"Experimental models to study epithelial-mesenchymal transition in proliferative vitreoretinopathy","volume":"24","author":"Datlibagi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oret.2026.06.005_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamaophthalmol.2025.2497","article-title":"Mammalian target rapamycin inhibition as a therapeutic target for prevention of proliferative vitreoretinopathy","volume":"149","author":"Alsoudi","year":"2025","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:40:50Z","timestamp":1790754050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2468653026002976"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.06.005","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracycline-class Antibiotics for Proliferative Retinopathy Prevention: Still Too Many Unanswered Questions","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.04.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology, Inc.","name":"copyright","label":"Copyright"}]}}